Angeles Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,611
| Closed | -$286K | – | 32 |
|
|
2024
Q4 | $286K | Sell |
1,611
-95
| -6% | -$16.9K | 0.01% | 146 |
|
|
2024
Q3 | $337K | Buy |
1,706
+62
| +4% | +$12.2K | 0.02% | 153 |
|
|
2024
Q2 | $282K | Sell |
1,644
-1,415
| -46% | -$243K | 0.01% | 168 |
|
|
2024
Q1 | $557K | Buy |
3,059
+371
| +14% | +$67.6K | 0.03% | 101 |
|
|
2023
Q4 | $417K | Buy |
2,688
+165
| +7% | +$25.6K | 0.03% | 121 |
|
|
2023
Q3 | $376K | Sell |
2,523
-1,052
| -29% | -$157K | 0.03% | 114 |
|
|
2023
Q2 | $482K | Buy |
3,575
+603
| +20% | +$81.2K | 0.04% | 69 |
|
|
2023
Q1 | $474K | Buy |
+2,972
| New | +$474K | 0.04% | 61 |
|
|
2022
Q1 | – | Sell |
-3,188
| Closed | -$432K | – | 121 |
|
|
2021
Q4 | $432K | Buy |
+3,188
| New | +$432K | 0.02% | 133 |
|